Pulling SEC filings + quote and writing the call…

Vericel Corp
Next earnings Jul 29, 2026 · consensus $-0.03 EPS, $74.1M rev
Last earnings -4.5% on 2026-05-07
Revenue grew 16.5% YoY.
Middling fundamentals and a rich price (~72% above fair value) leave little margin of safety — a wait-and-see.
Sources: SEC EDGAR (CIK 0000887359, latest 10-Q filed 2026-05-07) · as of 6/26/2026, 6:37:17 PM.
Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.
Vericel Corp shows $276M in FY2025 revenue (+16.5% YoY), a 6.0% net margin, and 4.7% ROE.
The risks, catalysts, 12-month price target and the cited SEC figures behind this rating — with Pro.
Unlock with Pro€15/mo · cancel anytime
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $153M | $164M | $198M | $237M | $276M |
| Gross profit | $106M | $110M | $136M | $172M | $206M |
| Operating income | -$7.85M | -$17.1M | -$6.46M | $4.52M | $11.0M |
| Net income | -$7.47M | -$16.7M | -$3.18M | $10.4M | $16.5M |
| Diluted EPS | -$0.16 | -$0.35 | -$0.07 | $0.20 | $0.32 |
| Net margin | -4.9% | -10.2% | -1.6% | 4.4% | 6.0% |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
1047 tracked peers · median
Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.
Last 90 days: 0 open-market buys · 10 sales
| 2026-06-18 | Halpin Michael Chief Operating Officer | Exercise | 10.0K @ $16.66 | $167K |
| 2026-06-18 | Halpin Michael Chief Operating Officer | Sell | 10.0K @ $40.24 | $402K |
| 2026-06-18 | Flynn Sean C. Chief Legal Officer | Exercise | 15.0K @ $16.25 | $244K |
| 2026-06-18 | Flynn Sean C. Chief Legal Officer | Sell | 15.0K @ $40.21 | $603K |
| 2026-06-02 | Hopper Jonathan Mark Chief Medical Officer | Exercise | 4.38K @ $16.66 | $72.9K |
| 2026-06-02 | Hopper Jonathan Mark Chief Medical Officer | Sell | 4.38K @ $35.00 | $153K |
| 2026-05-13 | MCLAUGHLIN KEVIN F Director | Exercise | 3.50K @ $2.63 | $9.21K |
| 2026-05-13 | MCLAUGHLIN KEVIN F Director | Sell | 3.50K @ $32.83 | $115K |
| 2026-05-13 | MCLAUGHLIN KEVIN F Director | Exercise | 3.50K @ $13.05 | $45.7K |
| 2026-05-13 | MCLAUGHLIN KEVIN F Director | Sell | 3.50K @ $32.82 | $115K |
| 2026-05-11 | Wotton Paul K Director | Sell | 2.50K @ $33.05 | $82.6K |
| 2026-05-11 | Wotton Paul K Director | Sell | 7.50K @ $32.64 | $245K |